Research programme: phosphatidylcholine-complexed therapeutics - PLx

Drug Profile

Research programme: phosphatidylcholine-complexed therapeutics - PLx

Alternative Names: Indometacin/phosphatidylcholine; Indomethacin-PC; Indomethacin/phosphatidylcholine; Ketorolac/phosphatidylcholine; Meloxicam/phosphatidylcholine; Mesalazine (PL9100 5-ASA); Piroxicam-PC; Piroxicam/phosphatidylcholine; PL 4100; PL 4500; PL 9100 5-ASA

Latest Information Update: 28 Oct 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PLx Pharma
  • Class
  • Mechanism of Action Cyclooxygenase inhibitors; Lipoxygenase-cyclooxygenase inhibitors; Prostaglandin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Congenital heart defects
  • Discontinued Gout; Inflammation; Pain; Ulcerative colitis

Most Recent Events

  • 28 Oct 2018 No recent reports of development identified for preclinical development in Congenital-heart-disorders in USA (IV)
  • 20 Oct 2017 Discontinued - Preclinical for Ulcerative colitis, Pain, Inflammation and Gout (PO), and Pain (IV) in USA (PLx Pharma pipeline, October 2017)
  • 24 Oct 2016 Indomethacin (PL 4100) is still in preclinical development for Congenital-heart-disorders and pain in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top